相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
Anirban Das et al.
NATURE MEDICINE (2022)
Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer
Daniel P. Bondeson et al.
NATURE CANCER (2022)
Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade
Michelle Przedborski et al.
COMMUNICATIONS BIOLOGY (2021)
Processes shaping cancer genomes - From mitotic defects to chromosomal rearrangements
Kristina Keuper et al.
DNA REPAIR (2021)
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING
Marine Bruand et al.
CELL REPORTS (2021)
Will polygenic risk scores for cancer ever be clinically useful?
Amit Sud et al.
NPJ PRECISION ONCOLOGY (2021)
Mutational signature in colorectal cancer caused by genotoxic pks+E. coli
Cayetano Pleguezuelos-Manzano et al.
NATURE (2020)
Exploiting evolutionary steering to induce collateral drug sensitivity in cancer
Ahmet Acar et al.
NATURE COMMUNICATIONS (2020)
Polygenic risk scores: from research tools to clinical instruments
Cathryn M. Lewis et al.
GENOME MEDICINE (2020)
A census of pathway maps in cancer systems biology
Brent M. Kuenzi et al.
NATURE REVIEWS CANCER (2020)
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis
Mia Petljak et al.
CELL (2019)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-alpha-mediated cytotoxicity
Anne Margriet Heijink et al.
NATURE COMMUNICATIONS (2019)
The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations
Francesca Menghi et al.
CANCER CELL (2018)
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu et al.
CELL (2018)
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
Alexandra B. Keenan et al.
CELL SYSTEMS (2018)
Polygenic risk scores: a biased prediction?
Francisco M. De La Vega et al.
GENOME MEDICINE (2018)
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
Eileen E. Parkes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
Eileen E. Parkes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Andreas Hochhaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
Jingsong Zhang et al.
NATURE COMMUNICATIONS (2017)
Genome-wide association studies of cancer: current insights and future perspectives
Amit Sud et al.
NATURE REVIEWS CANCER (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib
Georgina V. Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Defining the consequences of genetic variation on a proteome-wide scale
Joel M. Chick et al.
NATURE (2016)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)